AstraZeneca shares sink 8% after $39 billion Alexion buyout
Neha Rathi Tuesday 15th of December 2020 05:05 AM
(0) (0)
The stock has also been under pressure recently amid questions surrounding the efficacy of AstraZeneca’s potential Covid-19 vaccine and the way the late-stage trials were handled.
Read more: HINDUSTANTIMES.COM
Leave Your Response